Skip to main content
Clinical Trials/CTRI/2024/03/064191
CTRI/2024/03/064191
Not yet recruiting
未知

Adverse Drug Reaction Monitoring In Patients Undergoing Chemotherapy At A State-Level Cancer Institute - NI

ot Available0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified siteHealth Condition 2: C00-D49- Neoplasms
Sponsor
ot Available
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
ot Available

Eligibility Criteria

Inclusion Criteria

  • Male and female patients of all age groups receiving cancer chemotherapy and developing at least one ADR.
  • Patients willing to join the study after giving a written informed consent.

Exclusion Criteria

  • Patients receiving concurrent radiotherapy along with chemotherapy.
  • Patient not willing to give consent for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials